Back to top

View the PFP Archive

ZACKS
Word to the Wise

The Dow was down only -0.16% on Monday. Sounds like a sleepy day for stocks, right?

WRONG!

The S&P 500 showed a bit more blemish at -0.49%. Then the pain parade really starts marching with:

-1.18% for Nasdaq

-1.30% for Russell 2000

-2.76% for Biotech Index (IBB)

This was certainly a Risk Off day where even the beloved Tesla lost nearly 4%. This is going to happen with a market that is probing to new highs. Every now and then there needs to be a gut check on valuations. After some excess gets squeezed out, the bull market will resume.

Word to the wise... Do keep a firmer eye on the valuations of your stocks going forward as those with excessive premiums will get punished the most in the end.

Featured Commentaries:

•  Roundtable Top Picks for the Week of Mar. 24th

•  Are Biotech Stocks Oversold?

•  Zacks #1 Ranked Precious Metals Funds

•  Tech Stock Roundup: MSFT Soars on iPad Rumor

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Sponsor

Only Zacks' Hottest Trades. Only $5.

Others pay thousands of dollars to see such privileged, sensitive information. But starting now, you can receive a hand selection of the Best of Our Best, just 2-3 buy recommendations each week at a tiny fraction of their worth.

These trades trounce the market in both win rate and performance. They also cost less than any other Zacks' service. Small wonder they have become by far our most popular.

Find out about these "Must Buys">>

Bull & Bear of the Day

Zacks Rank #1

Canadian Solar (CSIQ)

Solar energy may not be free like the sun itself, but this growth-at-a-stellar-price stock is the cheapest of them all.

 

Zacks Rank #5

Vail Resorts (MTN)

Estimates tumble down the mountain as the stock reaches new heights, valuation touches the sky.


Stock Picking Strategies

Natural Gas Rig Count Hits New 19-Yr Low  ››

Coal Industry Stock Outlook - March 2014  ››

Thoughts on Rising Rates  ››


Funds Commentary

Russia Mutual Funds to Watch on Ukraine Crisis  ››

3 ETFs Tumble Most on Biotech Sell-off  ››

A Comprehensive Guide to REIT ETFs  ››


Options Strategies

How To Determine the Correct Position Size  ››


Video Reports

Roundtable Top Picks for the Week of Mar. 24th

Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).

2 Revenue Weighted ETFs to beat the market

Revenues are arguably one of the best indicators of financial health of a firm.

This Week's Growth & Income Stocks: (MMC) (SSS)

Growth & Income Stock Strategist, Todd Bunton, highlights Marsh & McLennan (MMC) and Sovran Self Storage (SSS) on March 19, 2014.

Earnings HQ

Today's Noteworthy Earnings Before the Bell:   ››  WAGCCLMKCCUKHDS

Today's Noteworthy Earnings After the Bell:   ››  PVHFIVESCSGOMOGOL

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

Recent Earnings Winners

Company Symbol Reported Surprise %Price Chg
CYRELA BRAZIL RLY AD CYRBY Mar 24 +0.19% +3.36%
MANHATTAN BRIDGE CAPITAL INC LOAN Mar 24 +0.02% +3.31%
PETROCHINA CO LTD ADS REP 100 H PTR Mar 24 +3.05% +3.23%
CHINA RECYCLING ENERGY CORP CREG Mar 24 +0.07% +3.07%
CHINA PETROLEUM & CHEMICAL CORP SNP Mar 24 +1.82% +2.71%

See All »

Best Earnings ESP Stocks  

Company Symbol Consensus
Est.
Most
Accurate Est.
Reports Zacks Rank ESP
STRONGCO CORP T.SQP 0.10 0.11 Mar 25 1 +10.00
ACCENTURE PLC ACN 1.04 1.06 Mar 27 2 +1.92
G-III APPAREL GIII 0.47 0.49 Mar 25 2 +4.26
CLARCOR INC CLC 0.74 0.75 Mar 24 2 +1.35
GREENBRIER COS GBX 0.60 0.62 Apr 3 2 +3.33
Don't trade these stocks until you have read the Zacks ESP Guide

Sponsor

What's Today's Top Rated Mutual Fund?

Use the Zacks Mutual Fund Rank, a quantitative ratings system designed to help you find the best funds to beat the market. See which ones to buy, which to sell and track your favorite mutual fund family.

Get started now>>


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606

Please login to Zacks.com or register to post a comment.